Powered by

Maria Sharapova’s Imminent Return Stirs Debate on Wild Cards

INDIAN WELLS, Calif. — A year after the news of her positive doping test shook the BNP Paribas Open, Maria Sharapova again dominated conversation here in absentia.

Last March, on the eve of this tournament, Sharapova announced that she had tested positivefor the recently banned substance meldonium, an over-the-counter cardiac supplement for which hundreds of Russian athletes also tested positive.

After her two-year suspension by the International Tennis Federation was reduced to 15

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox